Belgium· BE-AMP-SAM456924-00

Alpharix-Tetra

A influenza, inaktiviert, spalt/split virus oder oberflächen-antigen product containing influenzavirus b split virion (inactivated), registered in Belgium by GlaxoSmithKline Biologicals. The same ATC class is registered in 11 of our 19 countries.

ATC J07BB02

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedAlpharix-TetraATCJ07BB02REGISTER NO.BE-AMP-SAM456924-00PACKS LISTED8CHECKEDSeptember 26, 2026

Where it is registered

Influenza, inaktiviert, spalt/split virus oder oberflächen-antigen is registered in 11 of 19 countries.

Countries holding a registration under ATC J07BB02 (influenza, inaktiviert, spalt/split virus oder oberflächen-antigen), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 7 of them publish a price we can compare per daily dose

Influenza, inaktiviert, spalt/split virus oder oberflächen-antigen · ATC J07BB02

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Influenzavirus B split virion (inactivated)
Manufacturer
GlaxoSmithKline Biologicals
Country
Belgium (BE)
ATC code
J07BB02
ATC class
Influenza, inaktiviert, Spalt/Split Virus oder Oberflächen-Antigen
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 8

1 priced
  • be_apb
    3745577
  • be_apb
    4176053
  • be_apb
    4299764
  • be_apb
    4489795
  • be_apb
    4670576
  • be_apb
    4777082
    EUR 17.74
  • be_apb
    7712714
  • be_apb
    3926664

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b04b52ff-670b-4a95-97e1-d25f2cfe39fc
GET /v1/drugs/b04b52ff-670b-4a95-97e1-d25f2cfe39fc?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Suspension for injection in pre-filled syringe",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Alpharix-Tetra",
  "name_fr": "Alpharix-Tetra",
  "name_nl": "Alpharix-Tetra",
  "amp_code": "SAM456924-00",
  "strengths": [
    "15.0000",
    "15.0000",
    "15.0000",
    "15.0000",
    "15.0000",
    "15.0000",
    "15.0000",
    "15.0000",
    "1.3000",
    "0.0050",
    "0.1000",
    "0.2000"
  ],
  "pack_count": 31,
  "substances": [
    "Influenzavirus B split virion (inactivated)",
    "Influenzavirus A-H1N1 split virion (inactivated)",
    "Influenzavirus A-H3N2 split virion (inactivated)",
    "Disodium Hydrogen Phosphate Dodecahydrate",
    "Formaldehyde - residual product",
    "Potassium Chloride",
    "Potassium Dihydrogen Phosphate",
    "Sodium Chenodeoxycholate - residual product",
    "Sodium Chloride",
    "Sucrose - residual product",
    "Polysorbate 80"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Influenza, Inactivated, Split Virus Or Surface Antigen",
  "authorisation_numbers": [
    "BE456924"
  ]
}

See everything about influenza, inaktiviert, spalt/split virus oder oberflächen-antigen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.